These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35965570)

  • 21. A-kinase interacting protein 1 as a potential biomarker of advanced tumor features and increased recurrence risk in papillary thyroid carcinoma patients.
    Zhang L; Tao H; Ke K; Ma C
    J Clin Lab Anal; 2020 Oct; 34(10):e23452. PubMed ID: 32643206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WDR34 affects PI3K/Akt and Wnt/β-catenin pathways to regulates malignant biological behaviors of glioma cells.
    Zuo J; Liu C; Ni H; Yu Z
    J Neurooncol; 2022 Jan; 156(2):281-293. PubMed ID: 34981299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway.
    Cui Y; Wu X; Lin C; Zhang X; Ye L; Ren L; Chen M; Yang M; Li Y; Li M; Li J; Guan J; Song L
    Oncogene; 2019 Jul; 38(27):5516-5529. PubMed ID: 30936461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GAB1 is upregulated to promote anaplastic thyroid cancer cell migration through AKT-MDR1.
    Song P; Xu H; He Y; Sun J; Xu Z; Huang P; Ge M; Zhang X; Ke Y; Cheng H
    Biochem Biophys Res Commun; 2022 Jun; 607():36-43. PubMed ID: 35366541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCAAT/Enhancer-binding protein-homologous protein sensitizes to SU5416 by modulating p21 and PI3K/Akt signal pathway in FRO anaplastic thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Horm Metab Res; 2013 Jan; 45(1):9-14. PubMed ID: 22918703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways.
    Li S; Mao L; Zhao F; Yan J; Song G; Luo Q; Li Z
    J Cancer; 2021; 12(14):4341-4354. PubMed ID: 34093834
    [No Abstract]   [Full Text] [Related]  

  • 27. Antimalarial drug artesunate is effective against chemoresistant anaplastic thyroid carcinoma via targeting mitochondrial metabolism.
    Ma L; Fei H
    J Bioenerg Biomembr; 2020 Apr; 52(2):123-130. PubMed ID: 32036542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells.
    Pilli T; Cantara S; Marzocchi C; Pacini F; Prabhakar BS; Castagna MG
    Endocrine; 2020 Jan; 67(1):117-123. PubMed ID: 31377969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma.
    Milošević Z; Banković J; Dinić J; Tsimplouli C; Sereti E; Dragoj M; Paunović V; Milovanović Z; Stepanović M; Tanić N; Dimas K; Pešić M
    Cell Oncol (Dordr); 2018 Aug; 41(4):409-426. PubMed ID: 29790111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of aggressive tumor progression of anaplastic thyroid cancer by p53.
    Hwang E; Kruhlak M; Wong N; Chari R; Kimura T; Cheng SY
    Am J Cancer Res; 2024; 14(9):4429-4444. PubMed ID: 39417187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM; Bai JY; Yang KX
    IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
    Chen H; Yan S; Dong L; Li X
    J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergy of GSK-J4 With Doxorubicin in KRAS-Mutant Anaplastic Thyroid Cancer.
    Lin B; Lu B; Hsieh IY; Liang Z; Sun Z; Yi Y; Lv W; Zhao W; Li J
    Front Pharmacol; 2020; 11():632. PubMed ID: 32477122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling.
    Pan S; Liang S; Wang X
    Life Sci; 2021 Aug; 278():119581. PubMed ID: 33961854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axis.
    Li Q; Yu D; Yu Z; Gao Q; Chen R; Zhou L; Wang R; Li Y; Qian Y; Zhao J; Rosell R; Tao M; Xie Y; Xu C
    Transl Lung Cancer Res; 2021 Feb; 10(2):936-954. PubMed ID: 33718034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.
    Kim KS; Min JK; Liang ZL; Lee K; Lee JU; Bae KH; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Choi MJ; Jo YS; Kim JM; Shong M
    Clin Cancer Res; 2012 Jun; 18(11):3071-8. PubMed ID: 22472175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.
    Saini S; Sripada L; Tulla K; Kumar P; Yue F; Kunda N; Maker AV; Prabhakar BS
    Cell Death Dis; 2019 Feb; 10(2):145. PubMed ID: 30760700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of AKIP1 predicts poor prognosis of patients with breast carcinoma and promotes cancer metastasis through Akt/GSK-3β/Snail pathway.
    Mo D; Li X; Li C; Liang J; Zeng T; Su N; Jiang Q; Huang J
    Am J Transl Res; 2016; 8(11):4951-4959. PubMed ID: 27904695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer.
    Wu J; Liang J; Liu R; Lv T; Fu K; Jiang L; Ma W; Pan Y; Tan Z; Liu Q; Qiu W; Ge M; Wang J
    Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37283515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Han K; Li C; Zhang X; Shang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.